These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 26069101

  • 1. Identification of miR-199a-5p in serum as noninvasive biomarkers for detecting and monitoring osteosarcoma.
    Zhou G, Lu M, Chen J, Li C, Zhang J, Chen J, Shi X, Wu S.
    Tumour Biol; 2015 Nov; 36(11):8845-52. PubMed ID: 26069101
    [Abstract] [Full Text] [Related]

  • 2. Identification of a plasma four-microRNA panel as potential noninvasive biomarker for osteosarcoma.
    Lian F, Cui Y, Zhou C, Gao K, Wu L.
    PLoS One; 2015 Nov; 10(3):e0121499. PubMed ID: 25775010
    [Abstract] [Full Text] [Related]

  • 3. A four serum-miRNA panel serves as a potential diagnostic biomarker of osteosarcoma.
    Huang C, Wang Q, Ma S, Sun Y, Vadamootoo AS, Jin C.
    Int J Clin Oncol; 2019 Aug; 24(8):976-982. PubMed ID: 31111286
    [Abstract] [Full Text] [Related]

  • 4. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
    Fan L, Qi H, Teng J, Su B, Chen H, Wang C, Xia Q.
    Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
    [Abstract] [Full Text] [Related]

  • 5. Circulating miR-215-5p and miR-642a-5p as potential biomarker for diagnosis of osteosarcoma in Mexican population.
    Monterde-Cruz L, Ramírez-Salazar EG, Rico-Martínez G, Linares-González LM, Guzmán-González R, Delgado-Cedillo E, Estrada-Villaseñor E, Valdés-Flores M, Velázquez-Cruz R, Hidalgo-Bravo A.
    Hum Cell; 2018 Oct; 31(4):292-299. PubMed ID: 29907935
    [Abstract] [Full Text] [Related]

  • 6. The diagnostic effect of serum miR-139-5p as an indicator in osteosarcoma.
    Zhou L, Ma X, Yue J, Chen T, Wang XY, Wang ZW, Pan J, Lin Y.
    Cancer Biomark; 2018 Oct; 23(4):561-567. PubMed ID: 30347602
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A three-plasma miRNA signature serves as novel biomarkers for osteosarcoma.
    Ouyang L, Liu P, Yang S, Ye S, Xu W, Liu X.
    Med Oncol; 2013 Mar; 30(1):340. PubMed ID: 23269581
    [Abstract] [Full Text] [Related]

  • 14. Increased expression of microRNA-191 as a potential serum biomarker for diagnosis and prognosis in human osteosarcoma.
    Wang T, Ji F, Dai Z, Xie Y, Yuan D.
    Cancer Biomark; 2015 Mar; 15(5):543-50. PubMed ID: 26406942
    [Abstract] [Full Text] [Related]

  • 15. Serum miR-542-3p as a prognostic biomarker in osteosarcoma.
    Li Q, Song S, Ni G, Li Y, Wang X.
    Cancer Biomark; 2018 Feb 14; 21(3):521-526. PubMed ID: 29103020
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. miR-421 is a diagnostic and prognostic marker in patients with osteosarcoma.
    Zhou S, Wang B, Hu J, Zhou Y, Jiang M, Wu M, Qin L, Yang X.
    Tumour Biol; 2016 Jul 14; 37(7):9001-7. PubMed ID: 26758431
    [Abstract] [Full Text] [Related]

  • 18. Circulating miR-375 and miR-199a-3p as potential biomarkers for the diagnosis of hepatocellular carcinoma.
    Yin J, Hou P, Wu Z, Wang T, Nie Y.
    Tumour Biol; 2015 Jun 14; 36(6):4501-7. PubMed ID: 25618599
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.